Not much in depth writing .. a bit heavy on the infographics
Here’s a taste
We’re welcoming 2025 by sharing highlights and milestones from our 38th year.
For many of us in the psychedelic community, 2024 will long be remembered as a challenging year. For us at MAPS and the countless people yearning for a new treatment option for PTSD, nothing is more painful than the FDA calling for more research before reconsidering the New Drug Application for MDMA-assisted therapy. The cascading impacts of this unexpected delay have forced us to make changes here at MAPS, but as we know, difficult is not the same as bad.
We have reflected on these profound shifts and honed our focus on the most impactful work we can do to further our multidisciplinary mission. We’ve also seen the seeds we planted in years past sprout, strengthening our belief that diligent, committed work will lead to meaningful change, even if the timelines aren’t always according to plan. We’ve highlighted some of our favorite accomplishments and impacts of 2024 below — simply click on the boxes to learn more about them.
In 2025, we look forward to forging transformative collaborations, educating people and communities, fostering novel research, and advancing psychedelic policy reforms toward healing and justice. The collective, interconnected web of MAPS and the psychedelic movement — people just like you — holds the seeds that, someday, will flower into safer, more equitable psychedelic access.
Thank you for being on this journey with us!
7
29
24,582
3,000+
9
72
6
23,354
13
5
4
35
Timeline
MAPS PBC Becomes Lykos Therapeutics
MAPS Unveils Improved Fiscal Sponsorship Program
Psychedelic Science Announced for June 16-20
MAPS Provides Psychedelic Crisis Assessment and Intervention Training to Denver’s First Responders
